Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wanders, Desiree ^a,b   Graff, Emily C ^a   White, B Douglas ^a   Judd, Robert L ^a  

^a AUBURN UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHAPERONE; DISULFIDE BOND A OXIDOREDUCTASE LIKE PROTEIN; ENDOPLASMIC OXIDOREDUCTIN 1 LIKE PROTEIN; ENDOPLASMIC RETICULUM PROTEIN 44; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ADIPONECTIN GENE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; INFLAMMATION; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; NIACIN; PANNICULITIS; TRANSCRIPTION FACTORS;

EID: 84881505295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071285     Document Type: Article

References (62)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209.
2. Grundy SM, (1997) Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95: 1-4.
3. Phan BA, Munoz L, Shadzi P, Isquith D, Triller M, et al. (2013) Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study. Am J Cardiol 111: 352-355.
4. Warnholtz A, Wild P, Ostad MA, Elsner V, Stieber F, et al. (2009) Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study. Atherosclerosis 204: 216-221.
5. Thoenes M, Oguchi A, Nagamia S, Vaccari CS, Hammoud R, et al. (2007) The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome. Int J Clin Pract 61: 1942-1948.
6. Canner PL, Furberg CD, McGovern ME, (2006) Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol 97: 477-479.
7. Kamanna VS, Kashyap ML, (2008) Mechanism of action of niacin. Am J Cardiol 101: 20B-26B.
8. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, et al. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355.
9. Lauring B, Taggart AK, Tata JR, Dunbar R, Caro L, et al. (2012) Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Sci Transl Med 4: 148ra115.
10. Plaisance EP, Grandjean PW, Brunson BL, Judd RL, (2008) Increased total and high-molecular weight adiponectin after extended-release niacin. Metabolism 57: 404-409.
11. Westphal S, Borucki K, Taneva E, Makarova R, Luley C, (2007) Extended-release niacin raises adiponectin and leptin. Atherosclerosis 193: 361-365.
12. Plaisance EP, Lukasova M, Offermanns S, Zhang Y, Cao G, et al. (2009) Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 296: E549-E558.
13. Linke A, Sonnabend M, Fasshauer M, Hollriegel R, Schuler G, et al. (2009) Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance. Atherosclerosis 205: 207-213.
14. Digby JE, McNeill E, Dyar OJ, Lam V, Greaves DR, et al. (2010) Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis 209: 89-95.
15. Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND, (2009) Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 297: F106-F113.
16. Kwon WY, Suh GJ, Kim KS, Kwak YH, (2011) Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-kappaB pathway. Crit Care Med 39: 328-334.
17. Digby JE, Martinez F, Jefferson A, Ruparelia N, Chai J, et al. (2012) Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109a Dependent Mechanisms. Arterioscler Thromb Vasc Biol 32: 669-76.
18. Gambhir D, Ananth S, Veeranan-Karmegam R, Elangovan S, Hester S, et al. (2012) GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest Ophthalmol Vis Sci 53: 2208-17.
19. Wu BJ, Chen K, Barter PJ, Rye KA, (2012) Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1. Circulation 125: 150-158.
20. Wu BJ, Yan L, Charlton F, Witting P, Barter PJ, Rye KA, (2010) Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Arterioscler Thromb Vasc Biol 30: 968-975.
21. Digby JE, Martinez F, Jefferson A, Ruparelia N, Chai J, et al. (2012) Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109a dependent mechanisms. Arterioscler Thromb Vasc Biol 32: 669-676.
22. Ganji SH, Qin S, Zhang L, Kamanna VS, Kashyap ML, (2009) Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 202: 68-75.
23. Lee JM, Robson MD, Yu LM, Shirodaria CC, Cunnington C, et al. (2009) Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 54: 1787-1794.
24. Li Z, Wang Y, van der Sluis RJ, van der Hoorn JW, Princen HM, Van EM, Van Berkel TJ, Rensen PC, Hoekstra M, (2012) Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice. Biochem Pharmacol 84: 821-9.
25. Sartipy P, Loskutoff DJ, (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100: 7265-7270.
26. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415.
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
28. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
29. Carlson LA, Oro L, (1962) The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. Acta Med Scand 172: 641-645.
30. Carlson LA, (1963) Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro. Acta Med Scand 173: 719-722.
31. Westphal S, Borucki K, Taneva E, Makarova R, Luley C, (2006) Adipokines and treatment with niacin. Metabolism 55: 1283-1285.
32. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I, (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663.
33. Park SK, Oh SY, Lee MY, Yoon S, Kim KS, et al. (2004) CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53: 2757-2766.
34. Deng Y, Scherer PE, (2010) Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 1212: E1-E19.
35. Seo JB, Moon HM, Noh MJ, Lee YS, Jeong HW, et al. (2004) Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J Biol Chem 279: 22108-22117.
36. Knowles HJ, te Poele RH, Workman P, Harris AL, (2006) Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol 71: 646-656.
37. Liu M, Liu F, (2010) Transcriptional and post-translational regulation of adiponectin. Biochem J 425: 41-52.
38. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, et al. (2007) Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 27: 3716-3731.
39. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF, (2007) Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251.
40. Lavigne PM, Karas RH, (2012) The Current State of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-Regression. J Am Coll Cardiol 61: 440-6.
41. Lukasova M, Malaval C, Gille A, Kero J, Offermanns S, (2011) Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121: 1163-1173.
42. Maury E, Brichard SM, (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314: 1-16.
43. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
44. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
45. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y, Brichard SM, (2002) Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J 367: 677-685.
46. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, et al. (2001) Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288: 1102-1107.
47. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761.
48. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099.
49. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527-E533.
50. Zhao SP, Yang J, Li J, Dong SZ, Wu ZH, (2008) Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Int J Cardiol 124: 172-178.
51. Wu ZH, Zhao SP, (2009) Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes. Pharmacology 84: 282-287.
52. Long Q, Lei T, Feng B, Yin C, Jin D, et al. (2010) Peroxisome proliferator-activated receptor-gamma increases adiponectin secretion via transcriptional repression of endoplasmic reticulum chaperone protein ERp44. Endocrinology 151: 3195-3203.
53. Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, et al. (2008) A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A 105: 18302-18307.
54. Qiang L, Wang H, Farmer SR, (2007) Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol 27: 4698-4707.
55. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, et al. (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 285: 6153-6160.
56. Ajuwon KM, Spurlock ME, (2005) Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288: R1220-R1225.
57. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
58. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS, (2010) Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59: 1171-1181.
59. Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, et al. (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 187: 5408-5418.
60. Suganami T, Ogawa Y, (2010) Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 88: 33-39.
61. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, et al. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 120: 3466-3479.
62. Schaub A, Futterer A, Pfeffer K, (2001) PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol 31: 3714-3725.